PharmaBlock Sciences (Nanjing), Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 734.44 million compared to CNY 621.3 million a year ago. Revenue was CNY 734.64 million compared to CNY 621.35 million a year ago.

Net income was CNY 153.1 million compared to CNY 381.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.77 compared to CNY 1.93 a year ago. Diluted earnings per share from continuing operations was CNY 0.77 compared to CNY 1.91 a year ago.